Mitochonic acid 5 attenuates age-related neuromuscular dysfunction associated with mitochondrial Ca2+ overload in

XinTong Wu1, Miku Seida1, Takaaki Abe2,3

  • 1Graduate School of Life Sciences, Tohoku University, Sendai, 980-8577, Japan.

Npj Aging
|August 1, 2023
PubMed

Insights

Mitochonic acid-5 (MA-5) shows promise as an anti-aging compound. It improved motor function and protected against age-related decline in muscle and neurons in model organisms.

Area of Science:

  • Biomedical research
  • Neuroscience
  • Aging research

Background:

  • Mitochondrial dysfunction is implicated in aging and various neuromuscular diseases.
  • Mitochondrial calcium (Ca2+) overload is a key factor in cellular aging and disease pathogenesis.

Purpose of the Study:

  • To investigate the therapeutic potential of Mitochonic acid-5 (MA-5) in models of mitochondrial disease and age-related neuromuscular decline.
  • To assess MA-5's effects on motor performance, mitochondrial health, and neuronal degeneration in Caenorhabditis elegans.

Main Methods:

  • Utilized Caenorhabditis elegans models for Duchenne muscular dystrophy and Parkinson's disease.
  • Administered 10 μM MA-5 to assess its impact on age-related motor decline.
  • Evaluated MA-5's effects on muscle mitochondria and dopaminergic neuron integrity.

Main Results:

  • MA-5 significantly attenuated age-related decline in motor performance in C. elegans.
  • MA-5 protected against the loss of muscle mitochondria associated with aging.
  • MA-5 prevented the degeneration of dopaminergic neurons linked to mitochondrial Ca2+ overload.

Conclusions:

  • MA-5 demonstrates efficacy in ameliorating key pathological features of age-related neuromuscular dysfunction.
  • These findings suggest MA-5 possesses anti-aging properties relevant to metazoan neuromuscular health.